March 7, 2018 / 9:44 PM / 7 months ago

BRIEF-Conatus Pharmaceuticals Q4 Revenue $8.8 Million

March 7 (Reuters) - Conatus Pharmaceuticals Inc:

* CONATUS PHARMACEUTICALS REPORTS 2017 FINANCIAL RESULTS AND PROGRAM UPDATES

* QTRLY ‍LOSS PER SHARE $0.15​

* Q4 EARNINGS PER SHARE VIEW $-0.17 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below